levonorgestrel butanoate lngb developmental code name levonorgestrel steroidal progestin group developed world health organization collaboration contraceptive development branch cdb national institute child health human development longacting injectable butanoate ester levonorgestrel acts prodrug levonorgestrel drug beyond phase iii stage clinical development marketed first described literature investigation potential clinical use since lngb investigation longlasting injectable contraceptive single intramuscular injection aqueous suspension mg lngb duration whereas injection mg duration drug also previously tested successfully combined injectable contraceptive estradiol hexahydrobenzoate formulation never lngb tested successfully combination testosterone buciclate longlasting injectable contraceptive men lngb may several advantages depot medroxyprogesterone acetate including use much lower comparative dosages reduced progestogenic side effects like hypogonadism amenorrhea rapid return fertility following drug wellestablished safety record owing use levonorgestrel oral contraceptive since httpsenwikipediaorgwikilevonorgestrelbutanoate